Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality.
INTRODUCTION:Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common reason for presentation to emergency departments (ED), but the management of these episodes is often heterogeneous regardless of their potential impact on short-term adverse outcomes. METHODS:This was a lon...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0208847 |
| _version_ | 1818591496872394752 |
|---|---|
| author | Fernando Casas-Mendez Maria Jose Abadías Oriol Yuguero Ignasi Bardés Ferran Barbé Jordi de Batlle |
| author_facet | Fernando Casas-Mendez Maria Jose Abadías Oriol Yuguero Ignasi Bardés Ferran Barbé Jordi de Batlle |
| author_sort | Fernando Casas-Mendez |
| collection | DOAJ |
| description | INTRODUCTION:Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common reason for presentation to emergency departments (ED), but the management of these episodes is often heterogeneous regardless of their potential impact on short-term adverse outcomes. METHODS:This was a longitudinal, retrospective study of all patients >40 years old admitted to the ED of two Spanish teaching hospitals for an AECOPD between January 1st and May 31st, 2016. All data were collected from electronic medical records. The primary outcomes were patient treatment at discharge and 90-day mortality. Logistic regression was used to model the determinants of 90-day mortality. RESULTS:Of the 465 included patients, 56% were prescribed a 3-drug combination at hospital discharge, 22% a 2-drug combination, 19% a single drug, and 4% other or no treatment. Approximately 8% of patients died within 90 days after an AECOPD. Multivariate logistic models revealed that having more than 2 severe exacerbations within the last 12 months (OR (95% CI): 15.12 (4.22-54.22)) and being prescribed a single drug at discharge (OR (95% CI): 7.23 (2.44-21.38)) were the main determinants of 90-day mortality after an AECOPD. CONCLUSIONS:This study reflects the real-life heterogeneity in the pharmacological treatments prescribed after an ED admission for an AECOPD and suggests the potential impact of suboptimal inhaled treatment strategies on 90-day mortality rates. |
| first_indexed | 2024-12-16T10:13:22Z |
| format | Article |
| id | doaj.art-253026636241496488378b6ddcc0553d |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-16T10:13:22Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-253026636241496488378b6ddcc0553d2022-12-21T22:35:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020884710.1371/journal.pone.0208847Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality.Fernando Casas-MendezMaria Jose AbadíasOriol YugueroIgnasi BardésFerran BarbéJordi de BatlleINTRODUCTION:Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common reason for presentation to emergency departments (ED), but the management of these episodes is often heterogeneous regardless of their potential impact on short-term adverse outcomes. METHODS:This was a longitudinal, retrospective study of all patients >40 years old admitted to the ED of two Spanish teaching hospitals for an AECOPD between January 1st and May 31st, 2016. All data were collected from electronic medical records. The primary outcomes were patient treatment at discharge and 90-day mortality. Logistic regression was used to model the determinants of 90-day mortality. RESULTS:Of the 465 included patients, 56% were prescribed a 3-drug combination at hospital discharge, 22% a 2-drug combination, 19% a single drug, and 4% other or no treatment. Approximately 8% of patients died within 90 days after an AECOPD. Multivariate logistic models revealed that having more than 2 severe exacerbations within the last 12 months (OR (95% CI): 15.12 (4.22-54.22)) and being prescribed a single drug at discharge (OR (95% CI): 7.23 (2.44-21.38)) were the main determinants of 90-day mortality after an AECOPD. CONCLUSIONS:This study reflects the real-life heterogeneity in the pharmacological treatments prescribed after an ED admission for an AECOPD and suggests the potential impact of suboptimal inhaled treatment strategies on 90-day mortality rates.https://doi.org/10.1371/journal.pone.0208847 |
| spellingShingle | Fernando Casas-Mendez Maria Jose Abadías Oriol Yuguero Ignasi Bardés Ferran Barbé Jordi de Batlle Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. PLoS ONE |
| title | Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. |
| title_full | Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. |
| title_fullStr | Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. |
| title_full_unstemmed | Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. |
| title_short | Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality. |
| title_sort | treatment strategies after acute exacerbations of chronic obstructive pulmonary disease impact on mortality |
| url | https://doi.org/10.1371/journal.pone.0208847 |
| work_keys_str_mv | AT fernandocasasmendez treatmentstrategiesafteracuteexacerbationsofchronicobstructivepulmonarydiseaseimpactonmortality AT mariajoseabadias treatmentstrategiesafteracuteexacerbationsofchronicobstructivepulmonarydiseaseimpactonmortality AT oriolyuguero treatmentstrategiesafteracuteexacerbationsofchronicobstructivepulmonarydiseaseimpactonmortality AT ignasibardes treatmentstrategiesafteracuteexacerbationsofchronicobstructivepulmonarydiseaseimpactonmortality AT ferranbarbe treatmentstrategiesafteracuteexacerbationsofchronicobstructivepulmonarydiseaseimpactonmortality AT jordidebatlle treatmentstrategiesafteracuteexacerbationsofchronicobstructivepulmonarydiseaseimpactonmortality |